COVID-19

COVID-19: What you need to know about the coronavirus pandemic on 26 August

A student wearing a protective face mask amid coronavirus disease (COVID-19) outbreak, stands on a mark for social distancing at a classroom of Takanedai Daisan elementary school, which practices various methods of social distancing in order to prevent the infection, in Funabashi, east of Tokyo, Japan July 16, 2020. REUTERS/Kim Kyung-Hoon - RC27UH9XY06Y

Schools are reopening around the world - with new measures in place, and also new cases. Image: REUTERS/Kim Kyung-Hoon

Joe Myers
Writer, Forum Agenda
Share:
Our Impact
What's the World Economic Forum doing to accelerate action on COVID-19?
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

COVID-19

  • This daily round-up brings you a selection of the latest news updates on the COVID-19 pandemic, as well as tips and tools to help you stay informed and protected.
  • Top stories: India passes 3.2 million confirmed cases; re-infection cases in Europe; German economy suffers record contraction.
Have you read?

1. How COVID-19 is affecting the globe

Confirmed cases of COVID-19 have now reached more than 23.9 million globally, according to the Johns Hopkins Coronavirus Resource Center. The number of confirmed coronavirus deaths now stands at more than 819,000.

Myanmar has reported its biggest daily rise in new cases - 70. It has reported six deaths and 574 infections since March.

Researchers in Australia hope to launch trials of an antibody therapy early next year. A large-scale trial of a vaccine could start before the end of 2020.

US colleges are grappling with an increase in coronavirus cases as classes resume.

coronavirus confirmed cases global
Global confirmed cases Image: Our World in Data

2. German antibody study

Around 6% of residents of a German town that was an early COVID-19 hotspot, had antibodies to the virus.

Researchers from the Robert Koch Institute for infectious diseases tested people in Bad Feilnbach, in the south of the country, between 23 June and 4 July. They found 2.6 times more infections that previously reported.

Of those who had antibodies, 14.5% had shown no symptoms. The highest prevalence of the virus was among 18-34 year-olds, at 8%.

The study is part of ongoing research of towns in Germany, and the Institute said it would wait for more results before drawing broader conclusions.

Discover

What is the World Economic Forum doing to manage emerging risks from COVID-19?

3. Re-infections in Europe

Two patients - one in Belgium and one in the Netherlands - are confirmed to have been re-infected with coronavirus.

The cases follow a report of re-infection from Hong Kong. The Belgian case saw a woman first contract COVID-19 in March before contracting a different strain in June.

The Dutch case saw an elderly patient contract a different strain.

“It is clear there has been a first and a second infection with a substantial quantity of virus. Enough to be able to determine the genetic code of the virus, that is what showed they were indeed different,” said Marion Koopmans, a leading virologist in the Netherlands and a member of the World Health Organization’s scientific advisory group.

But, she also cautioned that the patient had a weakened immune system, and that she didn't think re-infection was 'standard'.

The World Health Organization, in reference to the Hong Kong case, has also cautioned that more research is needed before conclusions can be drawn.

Loading...
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
COVID-19Global Health
Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Winding down COVAX – lessons learnt from delivering 2 billion COVID-19 vaccinations to lower-income countries

Charlotte Edmond

January 8, 2024

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum